Loteprednol etabonate
- Generic Name
- Loteprednol etabonate
- Brand Names
- Eysuvis, Inveltys, Lotemax
- Drug Type
- Small Molecule
- Chemical Formula
- C24H31ClO7
- CAS Number
- 82034-46-6
- Unique Ingredient Identifier
- YEH1EZ96K6
- Background
Loteprednol Etabonate (LE) is a topical corticoid anti-inflammatory. It is used in ophthalmic solution for the treatment of steroid responsive inflammatory conditions of the eye such as allergic conjunctivitis, uveitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and selected infective conjunctivitides. As a nasal...
- Indication
A number of prescription loteprednol etabonate ophthalmic products are specifically indicated for the treatment of post-operative inflammation and pain following ocular surgery .
- Associated Conditions
- Dry Eye Syndrome (DES), Eye Pain, Ocular Inflammation
- Associated Therapies
- -
Acute Ocular Pain Treatment Market 2034: Clinical Trials, Medication, Prevalence, Incidence
DelveInsight's report on the Acute Ocular Pain Market forecasts significant growth (2020-2034) in the US, EU4, UK, and Japan. Key companies include Formosa Pharmaceuticals, Surface Ophthalmics, Sun Pharma, Ocular Therapeutix, Kala Pharmaceuticals, and Bausch & Lomb. Recent FDA approvals and ongoing research are driving market dynamics, with treatments like DEXTENZA, INVELTYS, and LOTEMAX SM addressing post-operative pain. The market is expected to surge due to increasing prevalence and pipeline product launches.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath